Hem-Onc Fellows Network shared on Twitter (X):
“Dr. Rami Komrokji from Moffitt Cancer Center presenting updates on high risk MDS and how HSCT is the only curative treatment available.
✍️ All high risk MDS patients should be considered for transplant!”